ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0727

Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System

Eugene Looi1, Gergana Mishkova1 and Christina Downey2, 1Loma Linda University, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

Meeting: ACR Convergence 2022

Keywords: Fracture, osteoporosis, prevention, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Osteoporosis (OSP) is common, carries high morbidity, significant cost and remains underrecognized and undertreated by health care providers (1). At a university-based academic health system in Southern California, a Fracture Liaison Service (FLS) has been established to ensure secondary prevention. A dedicated OSP clinic was established in 2018. OSP specialists regularly provide education and collaboration with PCPs and IM residents rotate through a two-week OSP rotation. It would be expected that primary prevention (PP) of OSP fractures be higher than the national rate of ≈ 16% (2). The objective of this study is to examine how PP of fragility fractures is addressed in an academic health system with a dedicated OSP treatment and education team.

Methods: The outpatient electronic medical records of adults who qualified for OSP treatment based on FRAX score or T score between January and May 2022 were reviewed. Basic demographic information was noted. Patients with prior OSP fracture were excluded. The medical specialty of the physician referring for BMD testing was noted. Whether the patient was offered treatment was noted as were rates of treatment acceptance.

Results: 201 patient charts were reviewed, all qualifying for treatment. Seventy-four patients (37%) were on OSP treatment at time of chart review and 127 (63%) weren’t (Table 1). Differences between groups in age, ethnicity and lowest T score were not significant. For most untreated patients (70.8%) the DXA was not the first showing OSP. Rheumatologists were most likely to treat patients for OSP (46% of providers) and more likely to use biologics for severe OSP (Table 2). Almost half of the ordering physicians who did not treat when required were Family Medicine (48%). 58% of the patients who were treated were seen in the OSP clinic. 31.5% were seen in the OSP clinic but not treated. Only 9.4% of the untreated patients were offered treatment according to documented clinical notes.

Conclusion: This is an ongoing study. PP at our academic center surpassed the national average by 21%. Given the relatively higher rates of treatment in those either cared for by an OSP clinic or rheumatology, having access to providers with OSP experience is beneficial for patients. Significant care gaps remain. Areas of further study include determining reasons for not treating, including investigating PCP comfort with biologic use in OSP. The fact that 31.5% of untreated patients who were seen by an OSP specialist were not treated points toward treatment refusal rather than offering. Documentation of offering treatment in the notes may be lacking. Availability of OSP specialists increases primary prevention in OSP.

References

  1. Kanis, John A., et al. “The Osteoporosis Treatment Gap.” Journal of Bone and Mineral Research, vol. 29, no. 9, 2014, pp. 1926–28. doi:10.1002/jbmr.2202
  2. Weaver, Jessica, et al. “Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and Medicare Advantage Osteoporosis Patients.” Journal of Managed Care & Specialty Pharmacy, vol. 23, no. 7, 2017, pp. 735–44. doi:10.18553/jmcp.2017.23.7.735

Supporting image 1

Table 1: Comparison of Treated vs. Not Treated Osteoporosis Patients

Supporting image 2

Table 2: High Risk Osteoporosis Patients (T-score ≤ _3.0)


Disclosures: E. Looi, None; G. Mishkova, None; C. Downey, None.

To cite this abstract in AMA style:

Looi E, Mishkova G, Downey C. Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/primary-prevention-of-fractures-in-osteoporotic-patients-in-a-southern-california-academic-health-system/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-prevention-of-fractures-in-osteoporotic-patients-in-a-southern-california-academic-health-system/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology